References

• 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
• 2013Economic Costs of Diabetes in the U.S. in 20122,161 cited
• 2015The Economic Costs of Type 2 Diabetes: A Global Systematic Review838 cited
• 2012Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs819 cited
• 2002Revealing the cost of Type II diabetes in Europe391 cited
• 2011Unterschiede in der Versichertenstruktur von Krankenkassen und deren Auswirkungen für die Versorgungsforschung: Ergebnisse des Bertelsmann-Gesundheitsmonitors278 cited
• 2013Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older population260 cited
• 2005Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation - ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG)226 cited
• 2014Ermittlung standardisierter Bewertungssätze aus gesellschaftlicher Perspektive für die gesundheitsökonomische Evaluation212 cited
• 2006The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM Study200 cited
• 2004Cost-of-Illness Studies in Diabetes Mellitus197 cited
• 1999Patient Self-Reports in Pharmacoeconomic Studies136 cited
• 1999Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.124 cited